SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-21-000342
Filing Date
2021-04-29
Accepted
2021-04-29 16:48:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 ovid13g.htm SC 13G 60344
  Complete submission text file 0000935836-21-000342.txt   61847
Mailing Address 919 NW BOND STREET SUITE 204 BEND OR 97703
Business Address 919 NW BOND STREET SUITE 204 BEND OR 97703 541.647.5664
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90350 | Film No.: 21871548
SIC: 2834 Pharmaceutical Preparations